Irina A. Ronzina
Research Subjects
Irina A. Ronzina has a total of 92 co-authors. Here are the top co-authors by number of shared publications:
- Nataliia L. Sheremet
Krasnov Research Institute of Eye Diseases
16 shared publications - Viatcheslav M Sheludchenko
M.M. Krasnov Research Institute of Eye Diseases
9 shared publications N. V. Zhorzholadze
Research Institute of Eye Diseases, 11A Rossolimo St., Moscow, Russian Federation, 119021
5 shared publications- Nino V. Zhorzholadze
M.M. Krasnov Research Institute of Eye Diseases
5 shared publications - Tatiana V. Smirnova
Krasnov Research Institute of Eye Diseases
5 shared publications E E Kazarian
4 shared publications
Latest Publications
- 28 April 2026
- Published by Media Sphere Publishing Group in Russian Annals of Ophthalmology
- Vol. 142 (2) , 50-55
Clinical case of an inherited retinal disease with late manifestation
Rod-cone dystrophy (RCD) is one of the forms of inherited retinal diseases (IRDs) caused by photoreceptor degeneration and leading to significant loss of visual function. In some cases, patients with late-onset RCD do not independently report complaints typical of IRDs, and standard and additional ophthalmological examinations performed using conventional methods fail to reveal pathological changes, which complicates and delays diagnosis. This article presents a case of late-onset RCD diagnosed through the active identification of characteristic complaints, thorough medical history taking, and targeted use of modern functional and structural retinal imaging techniques with an extended visualization range.
- 28 April 2026
- Published by Media Sphere Publishing Group in Russian Annals of Ophthalmology
- Vol. 142 (2) , 50-55
Clinical case of an inherited retinal disease with late manifestation
Rod-cone dystrophy (RCD) is one of the forms of inherited retinal diseases (IRDs) caused by photoreceptor degeneration and leading to significant loss of visual function. In some cases, patients with late-onset RCD do not independently report complaints typical of IRDs, and standard and additional ophthalmological examinations performed using conventional methods fail to reveal pathological changes, which complicates and delays diagnosis. This article presents a case of late-onset RCD diagnosed through the active identification of characteristic complaints, thorough medical history taking, and targeted use of modern functional and structural retinal imaging techniques with an extended visualization range.
- 8 September 2025
- Published by Media Sphere Publishing Group in Russian Annals of Ophthalmology
- Vol. 141 (4) , 102-109
Electrophysiological methods in the diagnosis and monitoring of glaucoma
Primary open-angle glaucoma (POAG) is characterized by chronic progressive damage to the retinal ganglion cell layer (GCL) and their axons, leading to gradual visual function loss. Currently, the gold standards for structural and functional assessment of the retina in glaucoma are static automated perimetry (SAP) and optical coherence tomography (OCT). However, in clinical practice, data from SAP and OCT may be insufficient to reliably determine the stage of glaucomatous optic neuropathy, monitor its progression, or differentiate it from other causes of visual dysfunction. For these purposes we can use various modifications of electroretinography (ERG), visual evoked cortical potentials (VECPs), as well as electrophosphene testing — threshold retinal electrical sensitivity (TRES) and lability of the optic nerve (LON).
- 8 September 2025
- Published by Media Sphere Publishing Group in Russian Annals of Ophthalmology
- Vol. 141 (4) , 102-109
Electrophysiological methods in the diagnosis and monitoring of glaucoma
Primary open-angle glaucoma (POAG) is characterized by chronic progressive damage to the retinal ganglion cell layer (GCL) and their axons, leading to gradual visual function loss. Currently, the gold standards for structural and functional assessment of the retina in glaucoma are static automated perimetry (SAP) and optical coherence tomography (OCT). However, in clinical practice, data from SAP and OCT may be insufficient to reliably determine the stage of glaucomatous optic neuropathy, monitor its progression, or differentiate it from other causes of visual dysfunction. For these purposes we can use various modifications of electroretinography (ERG), visual evoked cortical potentials (VECPs), as well as electrophosphene testing — threshold retinal electrical sensitivity (TRES) and lability of the optic nerve (LON).
- Open Access
- 22 June 2024
- Published by IMA Press, LLC in Neurology, Neuropsychiatry, Psychosomatics
- Vol. 16 (3) , 52-57
Optic neuritis in various demyelinating diseases
The discovery of antibodies against aquaporin-4 (AQP4) and against myelinoligodendrocyte glycoprotein (MOG) confirmed the existence of two disease entities distinct from multiple sclerosis (MS) — neuromyelitis optica spectrum disorders (NMOSD) and myelinoligodendrocyte glycoprotein-associated disease (MOGAD). Demyelinating optic neuritis (ON) can be either idiopathic (iDON) or a manifestation of MS, NMOSD (AQP4-ON) or MOGAD (MOG-ON).Objective: to determine the clinical features of ON and to evaluate the diagnostic value of optical coherence tomography (OCT) in demyelinating diseases of the central nervous system.Material and methods. The study included 43 patients with demyelinating ON who were divided into three groups according to the underlying disease (NMOSD, MOGAD and MS/iDON). We assessed visual acuity (VA) in the acute phase and analyzed VA and average values of retinal nerve fiber layer thickness (RNFL) and retinal ganglion cell complex (RGC) thickness using OCT data 6 months after the onset of ON.Results. ON was observed in the onset of the disease in 75% of NMOSD patients, 62% of MOGAD patients and 86% of MS/iDON patients. In the MOGAD and NMOSD groups, bilateral ON was predominantly observed. In 65% of patients with MOGAD (MOG-ONr), a recurrent course of ON was observed. VA was significantly lower in patients with AQP4-ON in acute phase and comparable to the MOG-ONr group in the long-term phase. VA in the onset of MOG-ON with a single episode was comparable to that of MS/iDON (p=0.2), but recovery was less pronounced (p=0.03). The most significant thinning of the RNFL and RGC complex was observed in the AQP4-ON and MOG-ONr groups. In AQP4-ON and MOG-ON groups, restoration of VA up to 0.5 and higher was observed significantly more frequently in the group of patients receiving pulse therapy with glucocorticoids (p=0.018).Conclusion. The study showed the most pronounced structural and functional disturbances in the long-term phase of AQP4-ON and MOG-ONr. MOG-ON was characterized by a high frequency of relapses with the influence of this factor on VA and thinning of the retinal layers in the long-term.
- 22 June 2024
- Published by IMA Press, LLC in Neurology, Neuropsychiatry, Psychosomatics
- Vol. 16 (3) , 52-57
Open AccessOptic neuritis in various demyelinating diseases
The discovery of antibodies against aquaporin-4 (AQP4) and against myelinoligodendrocyte glycoprotein (MOG) confirmed the existence of two disease entities distinct from multiple sclerosis (MS) — neuromyelitis optica spectrum disorders (NMOSD) and myelinoligodendrocyte glycoprotein-associated disease (MOGAD). Demyelinating optic neuritis (ON) can be either idiopathic (iDON) or a manifestation of MS, NMOSD (AQP4-ON) or MOGAD (MOG-ON).Objective: to determine the clinical features of ON and to evaluate the diagnostic value of optical coherence tomography (OCT) in demyelinating diseases of the central nervous system.Material and methods. The study included 43 patients with demyelinating ON who were divided into three groups according to the underlying disease (NMOSD, MOGAD and MS/iDON). We assessed visual acuity (VA) in the acute phase and analyzed VA and average values of retinal nerve fiber layer thickness (RNFL) and retinal ganglion cell complex (RGC) thickness using OCT data 6 months after the onset of ON.Results. ON was observed in the onset of the disease in 75% of NMOSD patients, 62% of MOGAD patients and 86% of MS/iDON patients. In the MOGAD and NMOSD groups, bilateral ON was predominantly observed. In 65% of patients with MOGAD (MOG-ONr), a recurrent course of ON was observed. VA was significantly lower in patients with AQP4-ON in acute phase and comparable to the MOG-ONr group in the long-term phase. VA in the onset of MOG-ON with a single episode was comparable to that of MS/iDON (p=0.2), but recovery was less pronounced (p=0.03). The most significant thinning of the RNFL and RGC complex was observed in the AQP4-ON and MOG-ONr groups. In AQP4-ON and MOG-ON groups, restoration of VA up to 0.5 and higher was observed significantly more frequently in the group of patients receiving pulse therapy with glucocorticoids (p=0.018).Conclusion. The study showed the most pronounced structural and functional disturbances in the long-term phase of AQP4-ON and MOG-ONr. MOG-ON was characterized by a high frequency of relapses with the influence of this factor on VA and thinning of the retinal layers in the long-term.
- Open Access
- 3 July 2023
- Published by PE Polunina Elizareta Gennadievna in Ophthalmology in Russia
- Vol. 20 (2) , 363-372-372
Congenital Aniridia: Clinical Features and Therapeutic Approaches (Case Report)
A clinical case of congenital aniridia in combination with high degree hyperopia, congenital cataract, ophthalmohypertension, foveal hypoplasia is presented. The article analyzes the results of a complex of morphofunctional studies conducted before and after cataract surgery, presents practical data on the differential diagnosis of glaucoma and ophthalmohypertension and analyzes therapeutic approaches, including the use of a diaphragm contact lens and a three-component tear substitute Stillavit.
- 3 July 2023
- Published by PE Polunina Elizareta Gennadievna in Ophthalmology in Russia
- Vol. 20 (2) , 363-372-372
Open AccessCongenital Aniridia: Clinical Features and Therapeutic Approaches (Case Report)
A clinical case of congenital aniridia in combination with high degree hyperopia, congenital cataract, ophthalmohypertension, foveal hypoplasia is presented. The article analyzes the results of a complex of morphofunctional studies conducted before and after cataract surgery, presents practical data on the differential diagnosis of glaucoma and ophthalmohypertension and analyzes therapeutic approaches, including the use of a diaphragm contact lens and a three-component tear substitute Stillavit.
- Open Access
- 15 February 2022
- Published by Consilium Medicum in Consilium Medicum
- Vol. 24 (2) , 132-136
Optomyelitis associated with the presence of antibodies to myelin oligodendrocyte glycoprotein. Case report
Antibodies to myelin-oligodendrocyte glycoprotein (anti-MOG-IgG) is a specific biomarker that has been detected in peripheral blood from children with acute multiple encephalomyelitis (ADEM) as well as in adults with aquaporin-4 (AQP4), associated with seronegative opticoneuromyelitis spectrum disease (NMOSD), brainstem encephalitis, longitudinally disseminated transverse myelitis, and optic neuritis. Most experts now consider MOG-IgG-associated disorder (MOG-AD) an independent disease immunopathogenetically distinct from classical multiple sclerosis (MS) and aquaporin-4 (AQP4)-IgG-positive optomyelitis. Isolated, bilateral, and less frequently unilateral OH, with simultaneous or sequential involvement of the eyes, is the most frequent clinical manifestation of MOG-AD. Because of the significant overlap in the clinical and radiological picture, MOG-AD is often misdiagnosed as MS. Timely diagnosis is critical to ensure appropriate treatment. This article describes a clinical case of anti-MOG-IgG encephalomyelitis with late-onset ON initially diagnosed as MS.
- 15 February 2022
- Published by Consilium Medicum in Consilium Medicum
- Vol. 24 (2) , 132-136
Open AccessOptomyelitis associated with the presence of antibodies to myelin oligodendrocyte glycoprotein. Case report
Antibodies to myelin-oligodendrocyte glycoprotein (anti-MOG-IgG) is a specific biomarker that has been detected in peripheral blood from children with acute multiple encephalomyelitis (ADEM) as well as in adults with aquaporin-4 (AQP4), associated with seronegative opticoneuromyelitis spectrum disease (NMOSD), brainstem encephalitis, longitudinally disseminated transverse myelitis, and optic neuritis. Most experts now consider MOG-IgG-associated disorder (MOG-AD) an independent disease immunopathogenetically distinct from classical multiple sclerosis (MS) and aquaporin-4 (AQP4)-IgG-positive optomyelitis. Isolated, bilateral, and less frequently unilateral OH, with simultaneous or sequential involvement of the eyes, is the most frequent clinical manifestation of MOG-AD. Because of the significant overlap in the clinical and radiological picture, MOG-AD is often misdiagnosed as MS. Timely diagnosis is critical to ensure appropriate treatment. This article describes a clinical case of anti-MOG-IgG encephalomyelitis with late-onset ON initially diagnosed as MS.
- 1 January 2022
- Published by Media Sphere Publishing Group in Russian Annals of Ophthalmology
- Vol. 138 (6) , 44-54
Multifocal electroretinography in assessment of the functional state of the central retina in patients with retinitis pigmentosa
Пигментный ретинит (ПР) — наследственное заболевание, обусловленное различными генетическими мутациями. Развитие генной инженерии делает актуальным поиск методов исследования функций сетчатки, информативных при отборе пациентов для лечения. ЦЕЛЬ ИССЛЕДОВАНИЯ Оценить информативность мультифокальной электроретинографии (мфЭРГ) в диагностике функционального состояния центральной зоны сетчатки при ПР. МАТЕРИАЛ И МЕТОДЫ Обследовано 115 пациентов (228 глаз) с ПР и 15 человек (30 глаз) контрольной группы. Проведены стандартное офтальмологическое обследование, компьютерная периметрия, исследование цветового зрения, спектральная оптическая когерентная томография сетчатки, ганцфельд-электроретинография (гЭРГ), мфЭРГ. Оценивали взаимосвязь параметров мфЭРГ со степенью изменения гЭРГ, различных функциональных и морфологических показателей сетчатки. РЕЗУЛЬТАТЫ Острота зрения и показатели периметрии варьировали в широком диапазоне; гЭРГ была нерегистрируемой в 50,4% случаев; мфЭРГ удалось зарегистрировать в 214 (98,3%) глазах с разной степенью изменения остроты зрения, поля зрения и параметров гЭРГ. Выявлена положительная взаимосвязь средней степени между плотностью электрического биопотенциала сетчатки в зоне фовеа и парафовеа и остротой зрения (rs=0,68; rs=0,63), высокой степени — между плотностью суммарного биопотенциала центральной зоны сетчатки (DValue) и средней световой чувствительностью (rs=0,9), слабой степени — между DValue и толщиной и объемом сетчатки в зоне перифовеа (rs=0,37; rs=0,42), отрицательная корреляция средней степени — между средним дефектом световой чувствительности и плотностью электрического биопотенциала в периферических (4—5-м) «кольцах» мфЭРГ, DValue (rs= –0,67; rs= –0,65; rs= –0,69 соответственно). ЗАКЛЮЧЕНИЕ МфЭРГ позволяет выявить нарушение функций сетчатки на ранней стадии ПР, в глазах с высокой остротой зрения, нормальными параметрами центрального поля зрения и гЭРГ, а также при низкой остроте зрения, выраженном снижении световой чувствительности, нерегистрируемой гЭРГ. МфЭРГ может быть информативна при отборе пациентов с ПР для генной терапии.
- 1 January 2022
- Published by Media Sphere Publishing Group in Russian Annals of Ophthalmology
- Vol. 138 (6) , 44-54
Multifocal electroretinography in assessment of the functional state of the central retina in patients with retinitis pigmentosa
Пигментный ретинит (ПР) — наследственное заболевание, обусловленное различными генетическими мутациями. Развитие генной инженерии делает актуальным поиск методов исследования функций сетчатки, информативных при отборе пациентов для лечения. ЦЕЛЬ ИССЛЕДОВАНИЯ Оценить информативность мультифокальной электроретинографии (мфЭРГ) в диагностике функционального состояния центральной зоны сетчатки при ПР. МАТЕРИАЛ И МЕТОДЫ Обследовано 115 пациентов (228 глаз) с ПР и 15 человек (30 глаз) контрольной группы. Проведены стандартное офтальмологическое обследование, компьютерная периметрия, исследование цветового зрения, спектральная оптическая когерентная томография сетчатки, ганцфельд-электроретинография (гЭРГ), мфЭРГ. Оценивали взаимосвязь параметров мфЭРГ со степенью изменения гЭРГ, различных функциональных и морфологических показателей сетчатки. РЕЗУЛЬТАТЫ Острота зрения и показатели периметрии варьировали в широком диапазоне; гЭРГ была нерегистрируемой в 50,4% случаев; мфЭРГ удалось зарегистрировать в 214 (98,3%) глазах с разной степенью изменения остроты зрения, поля зрения и параметров гЭРГ. Выявлена положительная взаимосвязь средней степени между плотностью электрического биопотенциала сетчатки в зоне фовеа и парафовеа и остротой зрения (rs=0,68; rs=0,63), высокой степени — между плотностью суммарного биопотенциала центральной зоны сетчатки (DValue) и средней световой чувствительностью (rs=0,9), слабой степени — между DValue и толщиной и объемом сетчатки в зоне перифовеа (rs=0,37; rs=0,42), отрицательная корреляция средней степени — между средним дефектом световой чувствительности и плотностью электрического биопотенциала в периферических (4—5-м) «кольцах» мфЭРГ, DValue (rs= –0,67; rs= –0,65; rs= –0,69 соответственно). ЗАКЛЮЧЕНИЕ МфЭРГ позволяет выявить нарушение функций сетчатки на ранней стадии ПР, в глазах с высокой остротой зрения, нормальными параметрами центрального поля зрения и гЭРГ, а также при низкой остроте зрения, выраженном снижении световой чувствительности, нерегистрируемой гЭРГ. МфЭРГ может быть информативна при отборе пациентов с ПР для генной терапии.
- 1 January 2022
- Published by Media Sphere Publishing Group in Russian Annals of Ophthalmology
- Vol. 138 (2) , 5-14
Electrophysiological and psychophysical studies in assessment of visual functions in patients with hereditary optic neuropathy
ЦЕЛЬ ИССЛЕДОВАНИЯ Изучить возможности электрофизиологических и психофизических методов исследования в оценке функционального состояния ганглиозных клеток сетчатки и зрительного нерва при наследственной оптической нейропатии (НОН). МАТЕРИАЛ И МЕТОДЫ Обследовано 60 пациентов (118 глаз) с генетически подтвержденным диагнозом НОН. Проведены компьютерная периметрия (КП), спектральная оптическая когерентная томография, зрительные вызванные потенциалы (ЗВП) на вспышку и паттерн (пЗВП, вЗВП), фотопическая электроретинография с регистрацией фотопического негативного ответа (ФНО), исследовано цветовое зрение (ЦЗ). У 24 пациентов (46 глаз) оценивали динамику вышеперечисленных показателей до лечения и после 1 года наблюдения на фоне терапии, включающей митохондриально-адресованный антиоксидант — пластохинонилдецилтрифенилфосфония бромид (ПДТФ) в виде глазных капель. РЕЗУЛЬТАТЫ Основные компоненты пЗВП на паттерн 1,0° и 0,3° удалось зарегистрировать соответственно в 20 и 14% глаз пациентов с НОН с высокими зрительными функциями. После 1 года применения ПДТФ значимое уменьшение латентности пика Р100 было выявлено только в группе с длительностью заболевания ≤1,5 года на момент начала лечения (ppp<0,01). У пациентов с высокими суммарными зрительными функциями получена корреляционная связь между амплитудой ФНО, толщиной комплекса ганглиозных клеток и показателем глобальных потерь. ЗАКЛЮЧЕНИЕ Электрофизиологические показатели, наравне с ОЗ, КП и ЦЗ, являются основными методами обследования пациентов с НОН. Отмечено значимое уменьшение латентности пика Р2 вЗВП после 1 года применения ПДТФ в группе с длительностью заболевания ≤1,5 года на момент начала лечения. Амплитуда ФНО у пациентов с высокими зрительными функциями коррелирует со структурными изменениями комплекса ганглиозных клеток сетчатки и слоя нервных волокон сетчатки.
- 1 January 2022
- Published by Media Sphere Publishing Group in Russian Annals of Ophthalmology
- Vol. 138 (2) , 5-14
Electrophysiological and psychophysical studies in assessment of visual functions in patients with hereditary optic neuropathy
ЦЕЛЬ ИССЛЕДОВАНИЯ Изучить возможности электрофизиологических и психофизических методов исследования в оценке функционального состояния ганглиозных клеток сетчатки и зрительного нерва при наследственной оптической нейропатии (НОН). МАТЕРИАЛ И МЕТОДЫ Обследовано 60 пациентов (118 глаз) с генетически подтвержденным диагнозом НОН. Проведены компьютерная периметрия (КП), спектральная оптическая когерентная томография, зрительные вызванные потенциалы (ЗВП) на вспышку и паттерн (пЗВП, вЗВП), фотопическая электроретинография с регистрацией фотопического негативного ответа (ФНО), исследовано цветовое зрение (ЦЗ). У 24 пациентов (46 глаз) оценивали динамику вышеперечисленных показателей до лечения и после 1 года наблюдения на фоне терапии, включающей митохондриально-адресованный антиоксидант — пластохинонилдецилтрифенилфосфония бромид (ПДТФ) в виде глазных капель. РЕЗУЛЬТАТЫ Основные компоненты пЗВП на паттерн 1,0° и 0,3° удалось зарегистрировать соответственно в 20 и 14% глаз пациентов с НОН с высокими зрительными функциями. После 1 года применения ПДТФ значимое уменьшение латентности пика Р100 было выявлено только в группе с длительностью заболевания ≤1,5 года на момент начала лечения (ppp<0,01). У пациентов с высокими суммарными зрительными функциями получена корреляционная связь между амплитудой ФНО, толщиной комплекса ганглиозных клеток и показателем глобальных потерь. ЗАКЛЮЧЕНИЕ Электрофизиологические показатели, наравне с ОЗ, КП и ЦЗ, являются основными методами обследования пациентов с НОН. Отмечено значимое уменьшение латентности пика Р2 вЗВП после 1 года применения ПДТФ в группе с длительностью заболевания ≤1,5 года на момент начала лечения. Амплитуда ФНО у пациентов с высокими зрительными функциями коррелирует со структурными изменениями комплекса ганглиозных клеток сетчатки и слоя нервных волокон сетчатки.
- 1 January 2021
- Published by Media Sphere Publishing Group in Russian Annals of Ophthalmology
- Vol. 137 (5) , 114-121
Asymmetric form of pigmentary retinopathy (case study)
Монолатеральная пигментная ретинопатия (ПР) — редкая, нетипичная форма наследственной патологии сетчатки. Имитировать монолатеральную ПР могут различные виды вторичной ретинопатии, связанные с разными ненаследственными заболеваниями, травмой, интоксикацией. Поэтому важно определить причину зрительных нарушений и определить, о монолатеральной или асимметричной ПР идет речь. В статье представлен пример использования современных структурных и функциональных методов диагностики, в результате которого у пациентки с предполагаемой монолатеральной ПР была диагностирована асимметричная ее форма.
- 1 January 2021
- Published by Media Sphere Publishing Group in Russian Annals of Ophthalmology
- Vol. 137 (5) , 114-121
Asymmetric form of pigmentary retinopathy (case study)
Монолатеральная пигментная ретинопатия (ПР) — редкая, нетипичная форма наследственной патологии сетчатки. Имитировать монолатеральную ПР могут различные виды вторичной ретинопатии, связанные с разными ненаследственными заболеваниями, травмой, интоксикацией. Поэтому важно определить причину зрительных нарушений и определить, о монолатеральной или асимметричной ПР идет речь. В статье представлен пример использования современных структурных и функциональных методов диагностики, в результате которого у пациентки с предполагаемой монолатеральной ПР была диагностирована асимметричная ее форма.
- 1 January 2019
- Published by Media Sphere Publishing Group in Russian Annals of Ophthalmology
- Vol. 135 (5) , 31-37
Neurodegenerative changes of the retina in patients with diabetes
To investigate the morphological and functional state of the outer and inner layers of the retina in patients with diabetes mellitus (DM) and nonproliferative diabetic retinopathy (NPDR), to determine the presence and nature of the relationships between structural and functional changes. The study included 50 patients with subcompensated diabetes and NPDR and 40 people from the control group (healthy). All patients underwent OCT of the retina and optic nerve using RTVue-100 apparatus (Optovue, USA), as well as multifocal electroretinography (mfERG) and pattern electroretinography (PERG) on EP-1000 Multifocal device ('Tomey GmbH', Germany). When analyzing the results of OCT in patients with NPDR, a decrease in the total thickness of the retina and the thickness of its inner layers in the fovea and parafovea regions was found in comparison with the control group (p<0.001), thinning of the retinal ganglion cell (GCS) complex with increased focal losses (FLV) of up to 1.4% (Mann-Whitney test, p=0.001). In the group of patients with diabetes, there was a statistically significant decrease in the density and amplitude of P1 mfERG in all five 'rings' (Mann-Whitney test, p<0.001), increase in implicit time in the first 3 rings, decrease in P50 and N95 amplitude, increase in implicit time of N95 PERG (p=0.001) compared to the control group. The study revealed changes in the structure and functioning of the outer and inner layers of the retina in patients with NPDR, and established a reliable correlation between the morphological parameters (according to the OCT) and electrophysiological parameters (according to the mfERG and PERG data).
- 1 January 2019
- Published by Media Sphere Publishing Group in Russian Annals of Ophthalmology
- Vol. 135 (5) , 31-37
Neurodegenerative changes of the retina in patients with diabetes
To investigate the morphological and functional state of the outer and inner layers of the retina in patients with diabetes mellitus (DM) and nonproliferative diabetic retinopathy (NPDR), to determine the presence and nature of the relationships between structural and functional changes. The study included 50 patients with subcompensated diabetes and NPDR and 40 people from the control group (healthy). All patients underwent OCT of the retina and optic nerve using RTVue-100 apparatus (Optovue, USA), as well as multifocal electroretinography (mfERG) and pattern electroretinography (PERG) on EP-1000 Multifocal device ('Tomey GmbH', Germany). When analyzing the results of OCT in patients with NPDR, a decrease in the total thickness of the retina and the thickness of its inner layers in the fovea and parafovea regions was found in comparison with the control group (p<0.001), thinning of the retinal ganglion cell (GCS) complex with increased focal losses (FLV) of up to 1.4% (Mann-Whitney test, p=0.001). In the group of patients with diabetes, there was a statistically significant decrease in the density and amplitude of P1 mfERG in all five 'rings' (Mann-Whitney test, p<0.001), increase in implicit time in the first 3 rings, decrease in P50 and N95 amplitude, increase in implicit time of N95 PERG (p=0.001) compared to the control group. The study revealed changes in the structure and functioning of the outer and inner layers of the retina in patients with NPDR, and established a reliable correlation between the morphological parameters (according to the OCT) and electrophysiological parameters (according to the mfERG and PERG data).
- 1 January 2019
- Published by Media Sphere Publishing Group in Russian Annals of Ophthalmology
- Vol. 135 (5) , 267-271
Effectiveness of new techniques of intraocular stem cells transplantation in the treatment of retinitis pigmentosa
Retinitis pigmentosa (RP) is a degenerative retinal disease that leads to blindness. Recently, treatment methods based on new technologies have emerged. Among them is stem cells transplantation (SC). To make a systematic evaluation of the results of control clinical studies of cellular technologies for the treatment of RP. The key words - retinitis pigmentosa, stem cells, control study - were used to search literature databases PubMed (250), WOS (172), MEDLINE (32) for the last 5 years. According to preliminary criteria, 88 articles were selected, according to final criteria - 4 articles. A total of 25 patients with RP were found. Control points of the analysis were: baseline, 3 months and 12 months. Methods of analysis (events): visual acuity (VA) and flash electroretinogram (f-ERG). There was no VA increase in 15 (60%) of the blind (or with negligible vision of less than 20/1600 ENDRS) patients, and the f-ERG was unrecordable. In 10 patients (40%), VA improved from 0.1 to 0.4 logMAR and the amplitude of f-ERG increased at about 3 months after injection. At 12 months, the effect returned to the baseline values. The use of SC transplantation technology in RP helps achieve short-term (up to 3 months) positive changes in VA and f-ERG, which depend on the initial stage of RP and do not remain in the final stage. This evokes a question of repeated use of SC transplantation in the same patient.
- 1 January 2019
- Published by Media Sphere Publishing Group in Russian Annals of Ophthalmology
- Vol. 135 (5) , 267-271
Effectiveness of new techniques of intraocular stem cells transplantation in the treatment of retinitis pigmentosa
Retinitis pigmentosa (RP) is a degenerative retinal disease that leads to blindness. Recently, treatment methods based on new technologies have emerged. Among them is stem cells transplantation (SC). To make a systematic evaluation of the results of control clinical studies of cellular technologies for the treatment of RP. The key words - retinitis pigmentosa, stem cells, control study - were used to search literature databases PubMed (250), WOS (172), MEDLINE (32) for the last 5 years. According to preliminary criteria, 88 articles were selected, according to final criteria - 4 articles. A total of 25 patients with RP were found. Control points of the analysis were: baseline, 3 months and 12 months. Methods of analysis (events): visual acuity (VA) and flash electroretinogram (f-ERG). There was no VA increase in 15 (60%) of the blind (or with negligible vision of less than 20/1600 ENDRS) patients, and the f-ERG was unrecordable. In 10 patients (40%), VA improved from 0.1 to 0.4 logMAR and the amplitude of f-ERG increased at about 3 months after injection. At 12 months, the effect returned to the baseline values. The use of SC transplantation technology in RP helps achieve short-term (up to 3 months) positive changes in VA and f-ERG, which depend on the initial stage of RP and do not remain in the final stage. This evokes a question of repeated use of SC transplantation in the same patient.